U.S. FDA
FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease
FDA today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and…
Company newsroom
1 releases
FDA today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and…